|
T.TST
|
Review of SUSTOL delayed from Jan 17th to late February. Maybe the MCNA...
|
|
T.TST
|
You are dreaming.
|
|
T.TST
|
HT loves to count, don't ruin this for him.
|
|
T.TST
|
the 27% was from Telesta's own analysis. The FDA's analysis of the...
|
|
T.TST
|
I would think that the black box warning would be something like: "...
|
|
T.TST
|
So what that means is that MCNA clearly doesn't meet the minimum...
|
|
T.TST
|
It's gotta be the former, everyone knows you don't "discuss...
|
|
T.TST
|
I really don't think there's anything more that they can say about...
|
|
T.TST
|
Really though, isn't someone who refuses cysectomy part of the group that...
|
|
T.TST
|
Narrow the indication. It seems pretty clear that this is the step forward...
|
|
T.TST
|
investderp wrote: Seems pretty stupid considering the FDA's...
|
|
T.TST
|
AdComm panel epxressed concerns about DFS rate calculations which is the main...
|
|
T.TST
|
That is because the bladder cancer population is primarily white male. They...
|
|
T.TST
|
Can anyone find out what the royalties will look like for Telesta? All the...
|
|
T.TST
|
Right, right, but they can't pitch this to the FDA as a reason to give...
|
|
T.TST
|
"especially if the TST Adcom travel team includes a couple dying...
|
|
T.TST
|
Nice find, do you know when those numbers are from? Approvals have increased...
|
|
T.TST
|
Alot of other good biotech's are down 20%-30% over the past few days...
|
|
T.TST
|
Ha! Oh man, I mixed them up with Viventia, which is phase III. Nevermind, I...
|
|
T.TST
|
Yes, we are aware of Theralase. Most people here would probably agree that it...
|